Aptima® BV and CV/TV Assay
The #1 reason your patient comes in
Approximately 10M women visit the OB/GYN each year for a vaginitis infection. Our test detects the three most common causes of infectious vaginitis–bacterial vaginosis, candida vaginitis and trichomoniasis—that make up to 95% of these cases.1,2,3
While yeast infection or candida vaginitis (CV) is usually a result of overgrowth of candida albicans, it can also be caused by the azole-resistant strain candida glabrata, which requires a different treatment pathway than C. albicans. “Trich” (TV), the most common curable STI, can contribute to more serious health outcomes if left untreated.4,5
Clear the confusion
around co-infection
- Pathogen coinfection can occur frequently in women with vaginitis. Approximately 20–30%
of women with bacterial vaginosis (BV) are coinfected with candida species. Coexistence of BV pathogens and T. vaginalis is even more common, with co-infection rates of 60–80%.6 - Most conventional methods of diagnosis to detect positive culture—including wet mount, microscopy, or laboratory examination—lack accuracy and are also not easily available.7
- In contrast, NAAT molecular tests are highly sensitive, detecting more co-infection cases than clinical diagnosis with wet mount, culture, and Amsel’s criteria.8
Pinpoint the problem with ultra-sensitive molecular testing8
Accurate diagnosis using the Aptima® Bacterial Vaginosis and Aptima® Candida/Trichomonas Vaginitis Assays provide objective tools for the clinician to accurately diagnose and treat patients.8
The Aptima® BV and CV/TV tests detect and qualitatively report results for the following organisms:9,10
- Candida species group (C. albicans, C. tropicalis, C. parapsilosis, C. dubliniensis)
- Candida glabrata
- Lactobacillus, Gardnerella vaginalis, Atopobium vaginae
- Trichomonas vaginalis